Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1129928/000112992822000036/form6kcanaccordhorizons2022.htm
June 2022
June 2022
June 2022
May 2022
May 2022
May 2022
May 2022
May 2022
May 2022
April 2022
Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1129928/000112992822000036/form6kcanaccordhorizons2022.htm
Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Oncolytics Biotech Inc.
Oncolytics Biotech Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Oncolytics Biotech Inc provided additional information to their SEC Filing as exhibits
Ticker: ONCY
CIK: 1129928
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001129928-22-000036
Submitted to the SEC: Tue Apr 12 2022 2:12:45 PM EST
Accepted by the SEC: Tue Apr 12 2022
Period: Tuesday, April 12, 2022
Industry: Pharmaceutical Preparations